Spots Global Cancer Trial Database for brain and nervous system
Every month we try and update this database with for brain and nervous system cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Depocyt® With Sorafenib in Neoplastic Meningitis | NCT00964743 | Neoplastic Meni... | DepoCyt Sorafenib | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Nivolumab Consolidation in Older (≥ 65) Patients With Primary CNS Lymphoma | NCT04022980 | Brain and Nervo... Eye and Orbit | Nivolumab | 65 Years - | Wake Forest University Health Sciences | |
| Depocyt® With Sorafenib in Neoplastic Meningitis | NCT00964743 | Neoplastic Meni... | DepoCyt Sorafenib | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| A Phase I Trial Using Combination Irinotecan and Thalidomide for Recurrent CNS Tumors | NCT00251797 | Brain and Nervo... Cancer | Irinotecan Thalidomide | 18 Years - | University of New Mexico | |
| Phase I Compare OS in Post-CyberKnife Radiosurgery Tx in 1-3 VS 4 or More Brain Metastases | NCT01778764 | Brain and Nervo... | 21 Years - 95 Years | Stanford University | ||
| Phase I Compare OS in Post-CyberKnife Radiosurgery Tx in 1-3 VS 4 or More Brain Metastases | NCT01778764 | Brain and Nervo... | 21 Years - 95 Years | Stanford University | ||
| Nivolumab Consolidation in Older (≥ 65) Patients With Primary CNS Lymphoma | NCT04022980 | Brain and Nervo... Eye and Orbit | Nivolumab | 65 Years - | Wake Forest University Health Sciences | |
| B7-H3 Chimeric Antigen Receptor T Cells (B7-H3CART) in Recurrent Glioblastoma Multiforme | NCT05474378 | Brain and Nervo... | B7-H3CART | 18 Years - | Stanford University | |
| Hypofractionated Stereotactic Irradiation (HFSRT) With Pembrolizumab and Bevacizumab for Recurrent High Grade Gliomas | NCT02313272 | Malignant Gliom... | Hypofractionate... Pembrolizumab Bevacizumab | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Hypofractionated Stereotactic Irradiation (HFSRT) With Pembrolizumab and Bevacizumab for Recurrent High Grade Gliomas | NCT02313272 | Malignant Gliom... | Hypofractionate... Pembrolizumab Bevacizumab | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Sorafenib, Valproic Acid, and Sildenafil in Treating Patients With Recurrent High-Grade Glioma | NCT01817751 | Glioblastoma Recurrent Adult... Malignant Gliom... WHO Grade III G... | sorafenib tosyl... valproic acid sildenafil citr... | 18 Years - | Virginia Commonwealth University | |
| Study Bendamustine Concurrent Whole Brain Radiation Brain Metastases From Solid Tumors | NCT00879073 | Brain Metastase... | Bendamustine | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Phase II Study of Irinotecan HCI for Recurrent Anaplastic Astrocytomas, Mixed Malignant Gliomas, and Oligodendrogliomas | NCT00360828 | Astrocytoma Glioma Oligodendroglio... | Irinotecan Hydr... Continued Irino... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
